The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((2S,3S)-3-(ethoxycarbonyl)oxirane-2-carbonyl)-isoleucyl-proline ID: ALA4533469
Cas Number: 134447-97-5
PubChem CID: 131790
Max Phase: Preclinical
Molecular Formula: C17H26N2O7
Molecular Weight: 370.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
Standard InChI: InChI=1S/C17H26N2O7/c1-4-9(3)11(15(21)19-8-6-7-10(19)16(22)23)18-14(20)12-13(26-12)17(24)25-5-2/h9-13H,4-8H2,1-3H3,(H,18,20)(H,22,23)/t9-,10-,11-,12-,13-/m0/s1
Standard InChI Key: RFNNDNGXWCBNGK-VLJOUNFMSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
25.2289 -17.7164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5872 -18.2389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7726 -18.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6019 -19.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3110 -19.5340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9216 -18.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4264 -17.8872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4795 -16.9392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9958 -17.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2216 -18.2389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8130 -17.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2216 -16.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8130 -16.1157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9958 -16.1157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0388 -16.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5872 -16.8207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0388 -18.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4474 -17.5298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.4474 -19.7651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.4474 -18.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1564 -19.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9736 -19.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3822 -20.0615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3822 -18.6475 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1994 -18.6475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6080 -17.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 1 1
3 4 1 0
4 5 1 0
5 6 1 0
2 6 1 0
1 7 2 0
1 8 1 0
11 10 1 6
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
12 15 1 6
9 16 2 0
2 9 1 0
17 18 2 0
19 20 1 0
20 21 1 0
19 21 1 0
20 17 1 6
22 23 2 0
25 26 1 0
24 25 1 0
22 24 1 0
21 22 1 1
10 17 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.40Molecular Weight (Monoisotopic): 370.1740AlogP: -0.08#Rotatable Bonds: 8Polar Surface Area: 125.54Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.81CX Basic pKa: ┄CX LogP: 0.37CX LogD: -2.89Aromatic Rings: ┄Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: 0.06
References 1. Schmitz J, Gilberg E, Löser R, Bajorath J, Bartz U, Gütschow M.. (2019) Cathepsin B: Active site mapping with peptidic substrates and inhibitors., 27 (1): [PMID:30473362 ] [10.1016/j.bmc.2018.10.017 ]